May 21, 2001
Guidant Announces Two New Members to its Board of Directors
Former HCFA Administrator and Current Eli Lilly and Company Executive Vice President Added to the Board
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) announced that Guidant's shareholders elected Nancy-Ann DeParle, who was nominated by the board in March, as a director for a three-year term at the company's annual meeting in Indianapolis earlier today. Guidant also announced today that its board of directors increased its membership to 14 and elected August M. Watanabe, M.D., as a director for a one-year term effective immediately.
Dr. Watanabe was named executive vice president, science and technology, of Eli Lilly and Company, in 1996. He had been a Lilly vice president and president of Lilly Research laboratories since 1994. He is a director of Lilly and a member of the company's corporate policy committee. Prior to joining Lilly in 1990 as a vice president of Lilly Research Laboratories, Dr. Watanabe had been a full-time faculty member (from 1971 to 1990) of the Department of Medicine of Indiana University School of Medicine. From 1983 to 1990 he was professor and chairman of the department of medicine.
Dr. Watanabe is also a director of the Indiana University Foundation, the Regenstrief Foundation, the Indiana State Symphony Society, the Park-Tudor Foundation, Christel House, and a member of the board of governors of the Riley Memorial Association.
Dr. Watanabe earned a B.S. degree in zoology from Wheaton College. He earned his M.D. from the Indiana University School of Medicine, where he then served his residency in internal medicine. He did additional postgraduate work in clinical pharmacology at the Laboratory of Clinical Science of the National Institute of Mental Health and a fellowship in cardiology at Indiana University Medical Center.
As previously announced, from 1997 to 2000, Ms. DeParle served as administrator of the Health Care Financing Administration (HCFA), where she was a key health policy advisor to President Clinton, and directed the Medicare, Medicaid, and State Children's Health Insurance (S-CHIP) programs. She resigned in October 2000 to become a fellow of the Institute of Politics and the Interfaculty Health Policy Forum at Harvard University. Ms. DeParle currently serves as a consultant on health policy and regulatory issues. Before joining HCFA, Ms. DeParle was associate director for health and personnel at the White House Office of Management and Budget, where she oversaw budget and policy matters relating to all federal health programs. In 1994, Time magazine selected DeParle as one of "America's 50 Most Promising Leaders Age 40 and Under."
Ms. DeParle received a B.A. degree from the University of Tennessee, her M.A. from Oxford University, which she attended as a Rhodes Scholar, and her J.D. from Harvard Law School.
A global leader in the medical technology industry, Guidant Corporation provides innovative, minimally invasive and cost-effective products and services for the treatment of cardiovascular and vascular disease.